These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29688950)

  • 41. Utility of 68Ga-PSMA-11 PET/CT in Imaging of Glioma-A Pilot Study.
    Sasikumar A; Kashyap R; Joy A; Charan Patro K; Bhattacharya P; Reddy Pilaka VK; Oommen KE; Pillai MRA
    Clin Nucl Med; 2018 Sep; 43(9):e304-e309. PubMed ID: 29939953
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PET Imaging Quantifying
    Cuda TJ; Riddell AD; Liu C; Whitehall VL; Borowsky J; Wyld DK; Burge ME; Ahern E; Griffin A; Lyons NJR; Rose SE; Clark DA; Stevenson ARL; Hooper JD; Puttick S; Thomas PA
    J Nucl Med; 2020 Nov; 61(11):1576-1579. PubMed ID: 32358088
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis.
    Perera M; Papa N; Roberts M; Williams M; Udovicich C; Vela I; Christidis D; Bolton D; Hofman MS; Lawrentschuk N; Murphy DG
    Eur Urol; 2020 Apr; 77(4):403-417. PubMed ID: 30773328
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intramuscular Granular Cell Tumor Detected on 68 Ga-PSMA PET/CT.
    Engin MN; Boz A
    Clin Nucl Med; 2024 Jul; 49(7):e319-e320. PubMed ID: 38689441
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients.
    Schmidkonz C; Cordes M; Goetz TI; Prante O; Kuwert T; Ritt P; Uder M; Wullich B; Goebell P; Bäuerle T
    Ann Nucl Med; 2019 Oct; 33(10):766-775. PubMed ID: 31338731
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Contribution of 5th minute and 2nd hour images to standard imaging in (
    Can C; Komek H
    Ann Nucl Med; 2020 Mar; 34(3):163-173. PubMed ID: 31808135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rectal Carcinoma on 68Ga-PSMA PET/CT.
    Huang YT; Fong W; Thomas P
    Clin Nucl Med; 2016 Mar; 41(3):e167-8. PubMed ID: 26571447
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of preoperative locoregional Ga-68 PSMA-11 PET-CT and mp-MRI results with postoperative histopathology of prostate cancer.
    Yilmaz B; Turkay R; Colakoglu Y; Baytekin HF; Ergul N; Sahin S; Tugcu V; Inci E; Tasci AI; Cermik TF
    Prostate; 2019 Jun; 79(9):1007-1017. PubMed ID: 31012125
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serous Cystadenoma of the Pancreas Showing Uptake on 68Ga PSMA PET/CT.
    Chan M; Schembri GP; Hsiao E
    Clin Nucl Med; 2017 Jan; 42(1):56-57. PubMed ID: 27764044
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Loss of PSMA Expression in Non-neuroendocrine Dedifferentiated Acinar Prostate Cancer.
    Bronsert P; Reichel K; Ruf J
    Clin Nucl Med; 2018 Jul; 43(7):526-528. PubMed ID: 29659395
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lumbar Osteophyte Avid on 68Ga-Prostate-Specific Membrane Antigen PET/CT.
    Jochumsen MR; Madsen MA; Gammelgaard L; Bouchelouche K
    Clin Nucl Med; 2018 Jun; 43(6):456-457. PubMed ID: 29538033
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Frusemide aids diagnostic interpretation of
    Fennessy N; Lee J; Shin J; Ho B; Ali SA; Paschkewitz R; Emmett L
    J Med Imaging Radiat Oncol; 2017 Dec; 61(6):739-744. PubMed ID: 28623852
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    Klingenberg S; Jochumsen MR; Ulhøi BP; Fredsøe J; Sørensen KD; Borre M; Bouchelouche K
    J Nucl Med; 2021 Feb; 62(2):214-220. PubMed ID: 32444374
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prostate penile metastasis: Incidence and imaging pattern on
    Tatkovic A; McBean R; Schoeman J; Wong D
    J Med Imaging Radiat Oncol; 2020 Aug; 64(4):499-504. PubMed ID: 32449823
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biphasic ⁶⁸Ga-PSMA-HBED-CC-PET/CT in patients with recurrent and high-risk prostate carcinoma.
    Sahlmann CO; Meller B; Bouter C; Ritter CO; Ströbel P; Lotz J; Trojan L; Meller J; Hijazi S
    Eur J Nucl Med Mol Imaging; 2016 May; 43(5):898-905. PubMed ID: 26563122
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 68Ga-PSMA Uptake in Angiolipoma.
    Dekker I; van der Leest M; van Rijk MC; Gerritsen WR; Arens AIJ
    Clin Nucl Med; 2018 Oct; 43(10):757-758. PubMed ID: 30153142
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    Sathekge M; Lengana T; Modiselle M; Vorster M; Zeevaart J; Maes A; Ebenhan T; Van de Wiele C
    Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):689-694. PubMed ID: 27822700
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recurrent Medullary Thyroid Carcinoma on 68Ga-Prostate-Specific Membrane Antigen PET/CT: Exploring New Theranostic Avenues.
    Arora S; Damle NA; Parida GK; Singhal A; Nalli H; Dattagupta S; Bal C
    Clin Nucl Med; 2018 May; 43(5):359-360. PubMed ID: 29485449
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 68Ga-PSMA Uptake in Middle Lobe Syndrome.
    Pedersen MA; Bouchelouche K; Vendelbo MH
    Clin Nucl Med; 2018 Oct; 43(10):e376-e377. PubMed ID: 30036250
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    Corfield J; Perera M; Bolton D; Lawrentschuk N
    World J Urol; 2018 Apr; 36(4):519-527. PubMed ID: 29344682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.